In comparison with Ztm control female mice, the BC treatment led to an upregulation of genes (App, Fbxw11, Nfkb1, Map3k7, Atf2, and Creb1) in the NF-kB pathway compared with untreated Ztm female mice. The gene discussed is MAP3K7; the disease is breast cancer.